Details for Patent: 9,101,543
✉ Email this page to a colleague
Which drugs does patent 9,101,543 protect, and when does it expire?
Patent 9,101,543 protects ABRAXANE and is included in one NDA.
Protection for ABRAXANE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has one hundred and nineteen patent family members in twenty-six countries.
Summary for Patent: 9,101,543
| Title: | Combinations and modes of administration of therapeutic agents and combination therapy |
| Abstract: | The present invention provides combination therapy methods of treating proliferative diseases (such as cancer) comprising a first therapy comprising administering to an individual an effective amount of a taxane in a nanoparticle composition, and a second therapy which may include, for example, radiation, surgery, administration of chemotherapeutic agents, or combinations thereof. Also provided are methods of administering to an individual a drug taxane in a nanoparticle composition based on a metronomic dosing regime. |
| Inventor(s): | Desai; Neil P. (Los Angeles, CA), Soon-Shiong; Patrick (Los Angeles, CA) |
| Assignee: | ABRAXIS BIOSCIENCE, LLC (Los Angeles, CA) |
| Application Number: | 13/585,696 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,101,543 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,101,543
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol-myers | ABRAXANE | paclitaxel | POWDER;INTRAVENOUS | 021660-001 | Jan 7, 2005 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,101,543
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1853250 | ⤷ Subscribe | C300673 | Netherlands | ⤷ Subscribe |
| European Patent Office | 1853250 | ⤷ Subscribe | CA 2014 00034 | Denmark | ⤷ Subscribe |
| European Patent Office | 1853250 | ⤷ Subscribe | PA2014022 | Lithuania | ⤷ Subscribe |
| European Patent Office | 1853250 | ⤷ Subscribe | 300673 | Netherlands | ⤷ Subscribe |
| European Patent Office | 1853250 | ⤷ Subscribe | 37/2014 | Austria | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
